Stock Quote: Search:
Free Zone | User's Groups | Biotech Values
Hide iBox (less information) | Add this message board as an RSS Feed Send a link via email Board Search:
Moderator: DewDiligence Assistants: Biowatch Boardmarks: 558
Created: 11/14/2002 1:12:59 PM Board type: Free

Biotech Values is a forum for discussing all facets
of biotech investing. The focus is on fundamental
analysis and avoiding scams. (Posts about stocks
that trade on the bulletin boards and pink sheets
and blatant pumps by professional promoters
will be subject to removal.)
 

    ReadMeFirst


Calendars
Clinical / Regulatory / Litigation
Scientific Meetings
Webcasts

Tables and Compilations
iHub's Greatest Hits
Recent Biotech Buyouts
Late-Stage Drug Candidates Looking for a Home 

new Hangouts -  Surveys -  Bans
Go to Post # or date Previous 50 Next 50
PostSubjectPosted ByTime
#90340  Sticky Note Pfizer, Medivation Drug May Help Huntington’s Disease Patients jbog 2/9/2010 3:26:28 AM
#90335  Sticky Note Denosumab Phase-3 Scorecard DewDiligence 2/9/2010 2:31:57 AM
#90322  Sticky Note Deno... Amgen (Nasdaq: AMGN) today announced that a pivotal, jbog 2/8/2010 8:23:21 PM
#90384   MDVN Huntington's Disease - The only nugget in iwfal 2/9/2010 12:18:22 PM
#90383   US approval This WEEKS ... BioSpecialist 2/9/2010 12:17:00 PM
#90382   Thanks efar, I read right over that when apljack 2/9/2010 11:35:56 AM
#90381   From clintrials, Medivation Phase III CONNECTION Trial Primary efar 2/9/2010 11:26:14 AM
#90380   I assume that IDIX has a right to DewDiligence 2/9/2010 11:03:17 AM
#90379   Note these Dimebon HD results are just the biomaven0 2/9/2010 10:50:14 AM
#90377   Maybe a bit of cruel streak in me ghmm 2/9/2010 10:39:11 AM
#90376   AEN’s share-repurchase “plan” hasn't been mentioned lately. LMAO DewDiligence 2/9/2010 10:38:57 AM
#90375   Reminder - Crestor's patent trial vs. six generic genisi 2/9/2010 10:38:27 AM
#90374   Adeona (f/k/a/ Pipex) has yet another CEO: DewDiligence 2/9/2010 10:33:37 AM
#90373   MDVN: "The Dimebon results in HD are at best apljack 2/9/2010 10:15:17 AM
#90372   AGN:Not sure how important this formulation is…All of DewDiligence 2/9/2010 9:13:04 AM
#90371   Haha, maybe the "medulla oblogata" along with the amygdala: Preciouslife1 2/9/2010 9:05:14 AM
#90370   sorry gensi and jbog for missing your posts! ghmm 2/9/2010 9:01:00 AM
#90369   MYGN yes they did mention the seasonal weakness of dewophile 2/9/2010 8:57:01 AM
#90368   MYGN weakness - perhaps also cause management did genisi 2/9/2010 8:46:01 AM
#90367   Re: Debiopharm/IDIX mcbio 2/9/2010 8:42:47 AM
#90366   AGN one more tidbit - Juvederm XC (dermal genisi 2/9/2010 8:29:24 AM
#90364   Teva believes that laquinimod has a big potential genisi 2/9/2010 8:25:31 AM
#90363   AMGN/D-mab - I have posted a while ago genisi 2/9/2010 8:24:35 AM
#90362   Biowatch et al: BIIB pre-announced 4Q09 Tysabri sales DewDiligence 2/9/2010 7:59:43 AM
#90361   BIIB reports 4Q & full-year results; CC 8:30AM Biowatch 2/9/2010 7:54:23 AM
#90359   XOMA Initiates Phase 2b Dose-Ranging Clinical Trial of nuere 2/9/2010 7:17:02 AM
#90358   The EMEA just issued a “five-year plan”: DewDiligence 2/9/2010 7:11:12 AM
#90357   Pfizer Expands e-Payment Drug Discounts in Emerging Markets DewDiligence 2/9/2010 7:09:28 AM
#90356   [OT] It cracks me up how Dow Jones DewDiligence 2/9/2010 7:04:38 AM
#90355   I find it hard to believe that D-mab DewDiligence 2/9/2010 6:56:10 AM
#90354   Genoptix, Momenta Shares Headed for Gains go seek 2/9/2010 6:54:44 AM
#90353   From Alex To -- AMGN: Could drbio45 2/9/2010 6:36:14 AM
#90351   thank you rkrw drbio45 2/9/2010 6:29:49 AM
#90350   Debiopharm’s PR on the NVS deal for Debio DewDiligence 2/9/2010 6:28:14 AM
#90349   jbog et al Re: D-mab and ONJ DewDiligence 2/9/2010 5:28:42 AM
#90348   P3, Deno jbog 2/9/2010 5:02:16 AM
#90347   UK’s NICE rejects Afinitor, Tasigna, and Sprycel as DewDiligence 2/9/2010 4:41:46 AM
#90346   FDA approves Crestor (as expected) for patients with DewDiligence 2/9/2010 4:37:39 AM
#90345   Clinical / Regulatory / Litigation Calendar DewDiligence 2/9/2010 3:51:35 AM
#90344   There must be a lot of people on DewDiligence 2/9/2010 3:49:20 AM
#90343   Brain injury linked to gambling Biowatch 2/9/2010 3:46:57 AM
#90342   The ONJ rate of ~2% in the D-mab DewDiligence 2/9/2010 3:46:39 AM
#90341   The Dimebon results in HD are at best DewDiligence 2/9/2010 3:31:04 AM
#90340   Pfizer, Medivation Drug May Help Huntington’s Disease Patients jbog 2/9/2010 3:26:28 AM
#90339   Nothing new from the BioCEO presentation (eom). DewDiligence 2/9/2010 2:50:11 AM
#90338   Re: Latisse DewDiligence 2/9/2010 2:48:40 AM
#90337   Re: Denosumab trifecta in metastatic cancerSurprised no one DewDiligence 2/9/2010 2:39:36 AM
#90336   That's a trifecta for denosumab in metastatic cancer (eom). DewDiligence 2/9/2010 2:37:00 AM
#90335   Denosumab Phase-3 Scorecard DewDiligence 2/9/2010 2:31:57 AM
#90334   HCV: Most Likely to Succeed (IMHO) DewDiligence 2/9/2010 2:21:49 AM
#90333   NVS Licenses Debio 025 Cyclophilin Inhibitor for HCV DewDiligence 2/9/2010 2:17:16 AM
#90332   Does the benefit of delaying Time to Skeletal p3analyze 2/8/2010 11:06:04 PM
#90331   AMGN: Surprised no one posted about their prostate cancer ghmm 2/8/2010 10:35:23 PM
new Hangouts -  Surveys -  Bans
Go to Post # or date Previous 50 Next 50

Advanced Search Browse By Category Upgrade!
© 2010 InvestorsHub.Com, Inc.